Mobile application to monitor inflammatory bowel disease patients on intravenous biologic treatment: a feasibility study.
Liselot W van ErpMarcel J M GroenenWendy HeidaJolien WisseBritt RoosenboomPeter J WahabPublished in: Scandinavian journal of gastroenterology (2021)
Monitoring of IBD patients treated with intravenous biologics using an app is feasible. We saw high compliance, sufficient app use, and high patient satisfaction. Moreover, health-care utilization was reduced and almost all patients preferred using the app over previous standard care (ClinicalTrials.gov NCT04254614).